Financhill
Back

Humacyte Stock Predictions

Humacyte Stock Forecast

  • Is Humacyte Stock Undervalued?
    The current Humacyte [HUMA] share price is $2.77. The Score for HUMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • HUMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Humacyte Stock Go Up Next Year?

Data Unavailable

Humacyte Stock Rating

Data Unavailable

Humacyte Stock Price History

Is HUMA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HUMA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
humacyte.com

52-Week Data

52-Week High:
9.97
52-Week Low:
1.15

Prediction Charts

Market Cap:
429.7M
Price in USD:
2.77
Volume:
6.6M
Beta:
1.66

Technical Analysis

SMA50:
1.84
SMA100:
2.88
SMA200:
4.08
52-Wk Change:
-64.07%

Stock Predictions

  • Is Humacyte stock public?
    Yes, Humacyte is a publicly traded company.
  • What is the Humacyte stock quote today?
    The Humacyte stock price is 2.77 USD today.
  • How to buy Humacyte stock online?
    You can buy Humacyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-9 1.24 1.19 1.25 1.18
May-12 1.25 1.32 1.33 1.21
May-13 1.57 1.73 1.80 1.47
May-14 1.77 1.87 2.05 1.70
May-15 1.90 1.89 1.95 1.68
May-16 1.91 2.24 2.26 1.79
May-19 2.16 2.23 2.36 2.05
May-20 2.22 2.49 2.51 2.00
May-21 2.46 2.34 2.54 2.25
May-22 2.32 2.40 2.49 2.17
May-23 2.33 2.53 2.53 2.29
May-27 2.59 2.48 2.63 2.45
May-28 2.48 2.63 2.72 2.41
May-29 2.68 2.77 2.88 2.63

Humacyte Earnings

Data Unavailable

Humacyte Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.95 per share, and an increase next year of $0.25 per share.

* Humacyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.